Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Short-Term Antiarrhythmic Therapy on Success Rate and QoL After Catheter Ablation for Atrial Fibrillation
2008-004500-32Phase 4Completed
- Sponsor
- Jesper Hastrup Svendsen
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Jesper Hastrup Svendsen. Primary endpoints: Ablation success rate at 6 months and Quality of life after ablation. Started Sep 2008; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2008-004500-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004500-32.